TipRanks
Advertisement
Advertisement

DE:1JS Stock Latest News

Shield Therapeutics updates total voting rights and share capital
Company AnnouncementsShield Therapeutics updates total voting rights and share capital
4h ago
Shield Therapeutics Updates Total Voting Rights as Iron Drug Growth Continues
PremiumCompany Announcements
Shield Therapeutics Updates Total Voting Rights as Iron Drug Growth Continues
29d ago
Shield Therapeutics Takes Full Control of U.S. ACCRUFeR Business to Boost Profitability
PremiumCompany Announcements
Shield Therapeutics Takes Full Control of U.S. ACCRUFeR Business to Boost Profitability
1M ago
Shield Therapeutics narrows losses as ACCRUFeR® growth and global milestones lift H1 revenue
PremiumCompany Announcements
Shield Therapeutics narrows losses as ACCRUFeR® growth and global milestones lift H1 revenue
1M ago
Shield Therapeutics updates total voting rights and underscores global iron therapy push
PremiumCompany Announcements
Shield Therapeutics updates total voting rights and underscores global iron therapy push
2M ago
Shield Therapeutics grows H1 revenue, pivots commercial strategy and appoints new CFO
PremiumCompany AnnouncementsShield Therapeutics grows H1 revenue, pivots commercial strategy and appoints new CFO
2M ago
Shield’s pediatric trial backs ferric maltol in childhood iron deficiency anemia
Premium
Company Announcements
Shield’s pediatric trial backs ferric maltol in childhood iron deficiency anemia
2M ago
Shield Therapeutics issues shares under performance plan while keeping other incentive schemes unchanged
Premium
Company Announcements
Shield Therapeutics issues shares under performance plan while keeping other incentive schemes unchanged
3M ago
Shield Therapeutics Secures Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
Shield Therapeutics Secures Strong Shareholder Backing at 2026 AGM
3M ago
Shield Therapeutics updates share capital as iron deficiency franchise expands globally
PremiumCompany Announcements
Shield Therapeutics updates share capital as iron deficiency franchise expands globally
4M ago
Shield Therapeutics awards CEO new share options to support growth of iron drug franchise
PremiumCompany Announcements
Shield Therapeutics awards CEO new share options to support growth of iron drug franchise
5M ago
Shield Therapeutics posts profitable Q1 as ACCRUFeR sales surge and CFO departs
PremiumCompany Announcements
Shield Therapeutics posts profitable Q1 as ACCRUFeR sales surge and CFO departs
5M ago
Shield Therapeutics Updates Total Voting Rights and Highlights Global Iron Therapy Franchise
PremiumCompany AnnouncementsShield Therapeutics Updates Total Voting Rights and Highlights Global Iron Therapy Franchise
5M ago
Shield Therapeutics Starts Japanese Phase II Trial of ACCRUFeR in Pulmonary Arterial Hypertension
Premium
Company Announcements
Shield Therapeutics Starts Japanese Phase II Trial of ACCRUFeR in Pulmonary Arterial Hypertension
5M ago
Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
Premium
Company Announcements
Shield Therapeutics Hits Record ACCRUFeR Sales and Turns Cash-Flow Positive in 2025
6M ago
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
PremiumCompany Announcements
Shield Therapeutics Gains Pediatric Boost as Ferric Maltol Data Published in Leading Journal
6M ago
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
PremiumCompany Announcements
Shield Therapeutics updates share capital and underscores global iron deficiency franchise
6M ago
Shield Therapeutics gains EMA backing to extend FeRACCRU use to adolescents
PremiumCompany Announcements
Shield Therapeutics gains EMA backing to extend FeRACCRU use to adolescents
6M ago
ProKidney appoints Greg Madison as chief commercial officer
PremiumThe Fly
ProKidney appoints Greg Madison as chief commercial officer
6M ago
PROK
Shield Therapeutics Advances ACCRUFeR Into China With NMPA Filing Acceptance
PremiumCompany AnnouncementsShield Therapeutics Advances ACCRUFeR Into China With NMPA Filing Acceptance
7M ago
Shield Therapeutics Updates Voting Rights as Iron Drug Expansion Continues
Premium
Company Announcements
Shield Therapeutics Updates Voting Rights as Iron Drug Expansion Continues
7M ago
Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use
Premium
Company Announcements
Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >